PERBEDAAN EFEKTIVITAS KOMBINASI METFORMIN DAN SULFONILUREA DENGAN KOMBINASI METFORMIN DAN PENGHAMBAT DPP-IV DALAM MENGONTROL HbA1c PASIEN DM TIPE 2
The Indonesian Ministry of Health states that the prevalence of diabetes mellitus (DM) is 20.4 million people and it is estimated that in 2030 it will reach 21.3 million people. The metformin group is currently the most widely prescribed drug for initial therapy as monotherapy. Based on the manageme...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
2021-11-26.
|
| Subjects: | |
| Online Access: | Link Metadata |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|